3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
19
Urinary Bladder Neoplasms
4
Neoplasms
2
Urothelial Bladder Cancer
1
Urologic Neoplasms
1
Urinary Bladder Diseases
1
Stomach Neoplasms
1
Recurrence
1
Prostate cancer, familial
1
Parotid Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Lung Neoplasms
1
Genetic Predisposition to Disease
1
Driving Under the Influence
1
Disease
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Blood Specimen Collection
9
Surveys and Questionnaires
5
Magnetic Resonance Spectroscopy
5
Biopsy
5
Prednisone
4
Colonoscopy
4
Biopsy, Fine-Needle
4
Tomography, X-Ray Computed
3
Surgical Procedures, Operative
3
Mammography
3
Magnetic Resonance Imaging
3
Liquid Biopsy
3
Lenalidomide
3
Interviews as Topic
3
Exercise
3
Diagnostic Tests, Routine
3
Cyclophosphamide
3
weifuchun
2
pembrolizumab
2
obinutuzumab
2
Urination
2
Preoperative Exercise
2
Positron Emission Tomography Computed Tomography
2
Observation
2
Methods
2
Melphalan
2
Immunohistochemistry
2
Hematologic Tests
2
Gemcitabine
2
Educational Status
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Disease
×
Multiparametric Magnetic Resonance Imaging
×
Clear all
NCT03730324
2023-03-23
ProBioM
Odense University Hospital
Phase NA
Completed
261 enrolled